Safety and efficacy outcomes
| DC Group | TT Group | DAPT Group | P | |
|---|---|---|---|---|
| Major or clinically relevant nonmajor bleeding (No.) (%) | 0 | 10 (23.8) | 1 (4) | .006 |
| Major bleeding (No.) (%) | 0 | 4 (9.5) | 0 | .138 |
| Efficacy outcomeStroke (No.) (%) | 0 | 0 | 1 (4) | .41 |
|  Stent thrombosis (No.) (%) | 1 (4.1) | 0 | 0 |